Compare Moderna, Inc. (MRNA) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance

Moderna, Inc.Trade

iShares 1 3 Year Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while iShares 1 3 Year Treasury Bond ETF trades at $81.9. The key difference: Moderna, Inc. is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

	MRNA	SHY
Market Cap	$23.60B	—
Sector	Health	Fixed Income
52-Week High	$81.80	$83.18
52-Week Low	$22.36	$81.79
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

SHY

View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About iShares 1 3 Year Treasury Bond ETF

SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.